Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Vogenx Appoints Richard Gorman as Chief Commercial Officer

PUBLIC · VOGXOct 09, 2026

Position

Chief Commercial Officer

Company

Vogenx

Richard Gorman
United StatesBiotechnologyHealth CareGenetics

Description

Vogenx has appointed Richard 'Rich' Gorman as Chief Commercial Officer, effective October 12, 2026. This move signals a ramp towards the commercialization of their drug, mizagliflozin.

Company Information

Company

Vogenx

Location

United States

About

Vogenx, Inc. is a biotechnology company focused on developing innovative therapies to address unmet medical needs. The primary business activities involve research and development of advanced genetic and cell-based treatments aimed at enhancing health outcomes. Key products include proprietary genetic therapies designed for various applications across regenerative medicine and disease treatment. The company serves markets primarily in the United States, with potential global outreach as product development progresses. Vogenx is positioned as an emerging growth company, indicating its focus on rapid growth and innovation in the biotechnology sector.

Fundz sees it the moment Vogenx changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vogenx's next move

Learn about Strategic plan

Vogenx changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.